Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
8 February 2021 |
Main ID: |
NCT00866983 |
Date of registration:
|
20/03/2009 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
|
Scientific title:
|
A Local, Multi-Centre, Extension, Open Label Access Study, To Provide Sildenafil Therapy For Patients Who Completed A1481244 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil , Prior To Reimbursement And Availability For Patients In Brazil. |
Date of first enrolment:
|
October 2008 |
Target sample size:
|
|
Recruitment status: |
No longer available |
URL:
|
https://clinicaltrials.gov/show/NCT00866983 |
Study type:
|
Expanded Access |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Brazil
| | | | | | | |
Contacts
|
Name:
|
Pfizer CT.gov Call Center |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Pfizer |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subject who completed the A1481244 study and are judged by the Investigator to derive
clinical benefit from continuous treatment with Sildenafil 20 mg therapy.
- Subject who resides in a Brazilian State where Sildenafil is not supplied by State
Health Secretary.
Exclusion Criteria:
- Pregnant or lactating women.
- Current participation in other studies and during study participation.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Pulmonary Arterial Hypertension
|
Intervention(s)
|
Drug: sildenafil (Revatio) 20 mg TID
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|